Rituximab in membranous nephropathy: is it a first-line treatment?

Authors	Gerald B Appel
Journal	Journal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 23 Issue 8 Pg. 1280-2 (Aug 2012) ISSN: 1533-3450 [Electronic] United States
PMID	22797189 (Publication Type: Editorial, Comment)
Chemical References	Antibodies, Monoclonal, Murine-Derived Immunologic Factors Rituximab
Topics	Antibodies, Monoclonal, Murine-Derived (therapeutic use) Female Glomerulonephritis, Membranous (drug therapy) Humans Immunologic Factors (therapeutic use) Male Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!